AI assistant
Sending…
NovoCure Ltd — Director's Dealing 2015
Oct 1, 2015
31949_dirs_2015-10-01_48062faf-23c6-4b19-878f-d2a4af308df5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Novocure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2015-10-01
Reporting Person: Palti Yoram (Director, Chief Technology Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Ordinary Shares | 1540927 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Options to Buy Ordinary Shares | $0.17 | 2016-12-25 | Ordinary Shares (147825) | Direct | |
| Series A Convertible Preferred Shares | $ | Ordinary Shares (130127) | Indirect |
Footnotes
F1: Professor Palti shares voting and investment power for the shares held by Bennet Limited.
F2: Fully vested and currently exercisable as of the date hereof.
F3: Pursuant to the issuer's memorandum & articles of association, all outstanding preferred shares of each series will automatically convert into ordinary shares upon consummation of the issuer's initial public offering.
F4: N/A
More from NovoCure Ltd
Proxy Solicitation & Information Statement
2026
May 21
Earnings Release
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Board/Management Information
2026
Apr 24
Board/Management Information
2026
Apr 9
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3